Summary
Acute myocardial infarction is most commonly initiated by fissuring of an atheromatous plaque. Through such fissures the blood is exposed to thrombogenic constituents of the intima, causing thrombotic obstruction of the coronary artery. Why plaque fissuring occurs is not known. Our investigation is to establish which types of plaque undergo fissuring by relating their mechanical with their cellular and biochemical properties; and to quantify the distribution of fissures. Results so far indicate that fissures occur predominantly in plaques with lipid pools in one segment of intima, and that the commonest single site of fissuring is that of maximal stress concentration as predicted by computer modelling. The results also suggest that arterial spasm at the immediate site of fissuring is not involved, as more than half the fissures occur at sites where there is no residual medial smooth muscle. Obstructive coronary thrombosis is initiated in most cases by plaque fissure with local haemorrhage which induces intravascular platelet aggregation. Recent observations with novel techniques have provided evidence that platelet aggregation in vivo is initiated by ADP and potentiated by thromboxane A2 and thrombin, with actual contribution of exposed collagen still undetermined. These observations provide an explanation for the limited effectiveness of any simple platelet-inhibiting drug, including Aspirin, by itself whenever arterial, eg. coronary or cerebral thrombosis is initiated by haemorrhages into atheromatous plaques. On the other hand, Aspirin is significantly effective when myocardial infarction follows unstable angina and when strokes follow transient episodes of cerebral ischaemia. This partial effectiveness can be explained through an action of Aspirin on platelets by assuming that, in such cases, their thrombo-embolic aggregation is initiated by haemodynamic effects of atheromatous lesions. Recently we discovered that the uptake of atherogenic low-density lipoprotein is accelerated by noradrenaline at its physiological blood concentrations (Shafi, Cusack & Born, 1989: Proc. Roy. Soc. B., 235, 289). This may help to explain the increased incidence of coronary thrombosis in conditions associated with elevated blood noradrenaline, including cigarette smoking and stress; and it may open new therapeutic approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Born, G. V. R., and Richardson, P. D., Activation time of blood platelets, J. Membr. Biol., 57:87–90 (1980)
Born, G. V. R., Görög, P., and Kratzer, M. A. A., Aggregation of platelets in damaged vessels, Phil. Trans. R. Soc. Lond. B., 294:241–250 (1981).
Born, G. V. R., Arterial thrombosis and its prevention, in: Proc. VIII World Congress, Cardiology. S. Hayase, S. Murao (eds). Amsterdam: Excerpta Medica 81–91 (1979).
Born, G. V. R., Fluid-mechanical and biochemical interactions in haemostasis, Br. Med. Bull., 33:193–197 (1977).
Born, G. V. R., Platelets in thrombogenesis: mechanism and inhibition of platelet aggregation, Ann. R. Coll. Surg. Engl., 36:200–206 (1965).
Born, G. V. R., and Kratzer, M. A. A., Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man, J. Physiol Lond, 354:419–429 (1984).
Born, G. V. R., The carotid plaque, in: Extracranial Cerebrovascular Disease: Diagnosis and Management, F. Robicsek (ed). New York: Macmillan (in press) (1985).
Cairns, J., Gent, M., Singer, J., Finnie, K., Froggatt, G., Holder, D., Jablonsky, G., Kostuk, W., Melendez, L., Myers, M., Sackett, D., Sealey, B. Q., and Tamer, P., A study of Aspirin (ASA) and sulfinpyrazone (S) in unstable angina, Circulation, 70:suppl 2, Abstract 1659 (1984).
Constantinides, P., Plaque fissures in human coronary thrombosis, J. Atheroscler. Res., 6:1–17 (1966).
Davies, M. J., and Thomas, T., Thepathological basis and microanatomy of occlusive thrombus formation in human coronary arteries, Phil. Trans. R. Soc. Lond. B., 294:225–229 (1981).
Davies, M. J., and Thomas, A., Thrombosis and acute coronary-artery lesions in sudden cardiac ischaemic death, New Engl. J. Med., 310:1137–1140 (1984).
Didisheim, P., Pavlovsky, M., and Kobayashi, I., Factors that influence or modify platelet function, Ann. N. Y. Acad. Sci., 201:307–315 (1972).
Fields, W. S., Lemak, R. F., and Frankowski, R. F., Controlled trials of Aspirin in cerebral ischaemia, Stroke, 8:301–328 (1977).
Friedman, M., and Byers, S. O., Induction of thrombi upon preexisting arterial plaques, Amer. J. Path., 46:567–75, (1965).
Hugues, J. C., Agglutination précoce des plaquettes au cours de la formation du clou hémostatique, Thromb. Diathès. haemorrh., 3:177–186 (1959).
Lewis, Jr., H. D., Davies, J. W., Archibald, D. G., Steinke, W. E., Smitherman, T. C., III Doherty, J. E., Schnaper, H. W., LeWinter, M. M., Linares, E., Maurice Pouget, J., Sabharwal, S. C., Chesler, E., and DeMots, H., Protective effects of Aspirin against acute myocardial infarction and death in men with unstable angina, New Engl. J. Med., 309:396–403 (1983).
Lusby, R. J., Ferrell, L. D., Ehrenfeld, W. K., Stoney, R. J., and Wylie, E. J., Carotid plaque haemorrhage: its role in production of cerebral ischaemia, Arch. Surg., 117:1479–1488 (1982).
Lusby, R. J., Machleder, H. I., Jeans, W., Skidmore, R., Woodcock, J. P., Clifford, P. C., and Baird, R. N., Vessel wall and blood flow dynamics in arterial diseases, Phil. Trans. R. Soc. Lond. B., 294:231–239 (1981).
May, G. S., Eberlein, K. A., Furberg, C. D., Passamain, E. R., and DeMets, D. S., Secondary prevention after myocardial infarction: a review of long-term trials, Prog. Cardiovas. Dis., 24:331–352 (1982).
Mustard, J. F., Moore, S., Packham, M. A., Kinlough Rathbone, R. L., Platelets, thrombosis and atherosclerosis, Proc. Biochem. Pharmacol., 13:312–325 (1977).
Mustard, J. F., Murphy E. A., Rowsell, H. C., and Downie, H. G., Factors influencing thrombus formation in vivo, Amer. J. Med., 33:621–647 (1962).
Richardson, P. D., Galletti, P. M., and Born, G. V. R., Regional administration of drugs to control thrombosis in artificial organs, Trans. Am. Soc. Artif. Intern. Organs., 22:22–29 (1976).
Rowntree, L. G., and Shionya, T., Studies in experimental extracorporeal thrombosis. Part I: Methods for the direct observation of extra-corporeal thrombus formation, J. Exp. Med., 46:7–12 (1927).
Turitto, V. T., and Baumgartner, H. R., Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells, Microvasc. Res., 5:167–79 (1975).
Wilner, G. D., Nossell, H. L., and LeRoy, E. C., Aggregation of platelets by collagen, J. Clin. Invest., 47:2616–2621 (1968).
Zawilska, K. M., Born, G. V. R., and Begent, N. A., Effect of ADP-utilising enzymes on the arterial bleeding time in rats and rabbits, Br. J. Haematol., 50:317–325 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Born, G.V.R. (1990). Coronary Thrombosis: Pathogenesis and Prevention. In: Liu, C.Y., Chien, S. (eds) Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis. Advances in Experimental Medicine and Biology, vol 281. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3806-6_36
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3806-6_36
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6697-3
Online ISBN: 978-1-4615-3806-6
eBook Packages: Springer Book Archive